Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 19.48 is 235% above its 5-year average of 5.82, near the high end of its 5-year range (0.75–19.48).
As of the fiscal period ended Tuesday, June 30, 2026. 261.21% above its 12-month average of 5.39.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 19.48.
CURRENT RATIO
19.48
CURRENT RATIO AVG TTM
5.39
CURRENT RATIO AVG 3Y
3.91
CURRENT RATIO AVG 5Y
5.82
CURRENT RATIO AVG 10Y
5.10
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+261.21%
CURRENT VS 3Y AVG
+397.90%
CURRENT VS 5Y AVG
+234.87%
CURRENT VS 10Y AVG
+281.72%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+419.44%
vs the sector median at left
Indaptus Therapeutics, Inc.
Market Cap
$293.30M
Current Ratio
19.48
TTM Avg
5.39
3Y Avg
3.91
5Y Avg
5.82
Market Cap
$292.59M
Current Ratio
13.28
TTM Avg
4.54
3Y Avg
4.54
5Y Avg
4.54
Market Cap
$288.79M
Current Ratio
4.70
TTM Avg
5.10
3Y Avg
7.75
5Y Avg
8.34
Market Cap
$285.55M
Current Ratio
6.63
TTM Avg
6.50
3Y Avg
6.00
5Y Avg
4.95
Market Cap
$285.42M
Current Ratio
45.02
TTM Avg
28.56
3Y Avg
20.10
5Y Avg
23.41
Market Cap
$281.54M
Current Ratio
31.35
TTM Avg
25.02
3Y Avg
20.04
5Y Avg
16.03
Market Cap
$280.37M
Current Ratio
4.69
TTM Avg
11.27
3Y Avg
11.27
5Y Avg
11.27
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | $293.30M | 19.48 | 5.39 | 3.91 | 5.82 |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $292.59M | 13.28 | 4.54 | 4.54 | 4.54 |
| Larimar Therapeutics, Inc. (LRMR)vs › | $288.79M | 4.70 | 5.10 | 7.75 | 8.34 |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.55M | 6.63 | 6.50 | 6.00 | 4.95 |
| Sagimet Biosciences Inc. (SGMT)vs › | $285.42M | 45.02 | 28.56 | 20.10 | 23.41 |
| Aurora Cannabis Inc. (ACB)vs › | $284.31M | 5.36 | 5.13 | 3.92 | 3.90 |
| Standard BioTools Inc. (LAB)vs › | $282.64M | 9.10 | 4.95 | 4.04 | 3.29 |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.54M | 31.35 | 25.02 | 20.04 | 16.03 |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $280.37M | 4.69 | 11.27 | 11.27 | 11.27 |
| Benitec Biopharma Inc. (BNTC)vs › | $309.19M | 34.00 | 44.34 | 25.02 | 19.51 |
Current Ratio
19.48
Quick Ratio
19.48
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 19.48 |
| 2026-03-31 | 2.34 |
| 2025-12-31 | 1.51 |
| 2025-09-30 | 2.88 |
| 2025-06-30 | 0.75 |
| 2025-03-31 | 1.90 |
| 2024-12-31 | 1.95 |
| 2024-09-30 | 3.42 |
| 2024-06-30 | 3.88 |
| 2024-03-31 | 6.70 |
| 2023-12-31 | 5.05 |
| 2023-09-30 | 7.12 |
| 2023-06-30 | 9.45 |
| 2023-03-31 | 12.15 |
| 2022-12-31 | 7.94 |
| 2022-09-30 | 10.27 |
| 2022-06-30 | 9.18 |
| 2022-03-31 | 10.03 |
| 2021-12-31 | 8.77 |
| 2021-09-30 | 7.59 |
| 2021-06-30 | 3.45 |
| 2021-03-31 | 0.86 |
| 2020-12-31 | 0.86 |
| 2020-09-30 | 3.89 |
| 2020-06-30 | 3.45 |
| 2020-03-31 | 2.64 |
| 2019-12-31 | 1.65 |
| 2019-09-30 | 1.57 |
| 2019-06-30 | 2.46 |
| 2019-03-31 | 3.26 |
| 2018-12-31 | 5.69 |
| 2018-09-30 | 9.21 |
| 2018-06-30 | 7.41 |
| 2018-03-31 | 8.24 |
| 2017-12-31 | 9.80 |
| 2017-09-30 | 19.90 |
| 2017-06-30 | 6.39 |
| 2017-03-30 | 0.00 |
| 2015-12-31 | 25.20 |
| 2015-09-30 | 17.75 |
| 2015-06-30 | 3.02 |
| 2015-03-30 | 0.00 |
